Study Highlights Real-Time Monitoring as a New Standard for Spinal Cord Stimulation Management

Recent research reveals that Biotronik Neuro's remote monitoring with real-time visibility into spinal cord stimulation (SCS) usage can support a more effective, long-term approach to managing implanted neurostimulation devices. Biotronik is a leading medical device company aimed at developing improvements for heart and blood vessel diseases. The research examined how continuous data on stimulation patterns and patient engagement can help clinicians better understand therapy adherence, optimize programming and identify issues earlier than traditional follow-up methods. Researchers claim that the approach addresses a long-standing gap in post-implant care, where limited visibility has made it difficult to assess how devices are actually used outside the clinic.

Spinal cord stimulation is widely used for chronic pain, but outcomes vary significantly over time. The study’s findings suggest that real-time utilization data could become a foundation for more proactive device management, aligning neuromodulation with broader trends toward connected medical devices and continuous care models in chronic disease treatment. Other key findings show that 96.8 percent of patients were actively using therapy with less than 1 percent of patients classified as virtual explants.

Posted by MedCloudInsider Editors on 01/05/2026